Exosome-mediated delivery of siRNA in vitro and in vivo

被引:477
作者
El-Andaloussi, Samir [1 ,2 ]
Lee, Yi [1 ]
Lakhal-Littleton, Samira [1 ]
Li, Jinghuan [1 ]
Seow, Yiqi [3 ]
Gardiner, Chris [4 ]
Alvarez-Erviti, Lydia [5 ]
Sargent, Ian L. [4 ]
Wood, Matthew J. A. [1 ]
机构
[1] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England
[2] Karolinska Inst, Dept Lab Med, Huddinge, Sweden
[3] Agcy Sci Technol & Res, Mol Engn Lab, Singapore, Singapore
[4] John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England
[5] UCL, Inst Neurol, Univ Dept Clin Neurosci, London, England
基金
英国惠康基金;
关键词
MULTIVESICULAR BODIES; DENDRITIC CELLS; MESSENGER-RNA; MICRORNAS; MECHANISM; DISEASE; BRAIN;
D O I
10.1038/nprot.2012.131
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The use of small interfering RNAs (siRNAs) to induce gene silencing has opened a new avenue in drug discovery. However, their therapeutic potential is hampered by inadequate tissue-specific delivery. Exosomes are promising tools for drug delivery across different biological barriers. Here we show how exosomes derived from cultured cells can be harnessed for delivery of siRNA in vitro and in vivo. This protocol first describes the generation of targeted exosomes through transfection of an expression vector, comprising an exosomal protein fused with a peptide ligand. Next, we explain how to purify and characterize exosomes from transfected cell supernatant. Next, we detail crucial steps for loading siRNA into exosomes. Finally, we outline how to use exosomes to efficiently deliver siRNA in vitro and in vivo in mouse brain. Examples of anticipated results in which exosome-mediated siRNA delivery is evaluated by functional assays and imaging are also provided. The entire protocol takes similar to 3 weeks.
引用
收藏
页码:2112 / 2126
页数:15
相关论文
共 23 条
[1]   Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[2]   Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo [J].
Andaloussi, Samir E. L. ;
Lehto, Taavi ;
Maeger, Imre ;
Rosenthal-Aizman, Katri ;
Oprea, Iulian I. ;
Simonson, Oscar E. ;
Sork, Helena ;
Ezzat, Kariem ;
Copolovici, Dana M. ;
Kurrikoff, Kaido ;
Viola, Joana R. ;
Zaghloul, Eman M. ;
Sillard, Rannar ;
Johansson, Henrik J. ;
Hassane, Fatouma Said ;
Guterstam, Peter ;
Suhorutsenko, Julia ;
Moreno, Pedro M. D. ;
Oskolkov, Nikita ;
Haelldin, Jonas ;
Tedebark, Ulf ;
Metspalu, Andres ;
Lebleu, Bernard ;
Lehtioe, Janne ;
Smith, C. I. Edvard ;
Langel, Uelo .
NUCLEIC ACIDS RESEARCH, 2011, 39 (09) :3972-3987
[3]   Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes [J].
Baj-Krzyworzeka, M ;
Szatanek, R ;
Weglarczyk, K ;
Baran, J ;
Urbanowicz, B ;
Branski, P ;
Ratajczak, MZ ;
Zembala, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (07) :808-818
[4]   APP and BACE1 miRNA Genetic Variability Has No Major Role in Risk for Alzheimer Disease [J].
Bettens, Karolien ;
Brouwers, Nathalie ;
Engelborghs, Sebastiaan ;
Van Miegroet, Helen ;
De Deyn, Peter P. ;
Theuns, Jessie ;
Sleegers, Kristel ;
Van Broeckhoven, Christine .
HUMAN MUTATION, 2009, 30 (08) :1207-1213
[5]   Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis [J].
Dragovic, Rebecca A. ;
Gardiner, Christopher ;
Brooks, Alexandra S. ;
Tannetta, Dionne S. ;
Ferguson, David J. P. ;
Hole, Patrick ;
Carr, Bob ;
Redman, Christopher W. G. ;
Harris, Adrian L. ;
Dobson, Peter J. ;
Harrison, Paul ;
Sargent, Ian L. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (06) :780-788
[6]   Cell-penetrating peptides:: Mechanisms and applications [J].
El-Andaloussi, S ;
Holm, T ;
Langel, Ü .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) :3597-3611
[7]   Peptide-Based Matrices as Drug Delivery Vehicles [J].
Ezzat, Kariem ;
El Andaloussi, Samir ;
Abdo, Rania ;
Langel, Ulo .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (09) :1167-1178
[8]   Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity [J].
Gibbings, Derrick J. ;
Ciaudo, Constance ;
Erhardt, Mathieu ;
Voinnet, Olivier .
NATURE CELL BIOLOGY, 2009, 11 (09) :1143-U223
[9]   Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal [J].
Godlewski, Jakub ;
Nowicki, Michal O. ;
Bronisz, Agnieszka ;
Williams, Shante ;
Otsuki, Akihiro ;
Nuovo, Gerard ;
RayChaudhury, Abhik ;
Newton, Herbert B. ;
Chiocca, E. Antonio ;
Lawler, Sean .
CANCER RESEARCH, 2008, 68 (22) :9125-9130
[10]   microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma [J].
Kefas, Benjamin ;
Godlewski, Jakub ;
Comeau, Laurey ;
Li, Yunqing ;
Abounader, Roger ;
Hawkinson, Michael ;
Lee, Jeongwu ;
Fine, Howard ;
Chiocca, E. Antonio ;
Lawler, Sean ;
Purow, Benjamin .
CANCER RESEARCH, 2008, 68 (10) :3566-3572